SERATEST RF LATEX DETERMINATION

System, Test, Rheumatoid Factor

SERAGEN DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Seragen Diagnostics, Inc. with the FDA for Seratest Rf Latex Determination.

Pre-market Notification Details

Device IDK840863
510k NumberK840863
Device Name:SERATEST RF LATEX DETERMINATION
ClassificationSystem, Test, Rheumatoid Factor
Applicant SERAGEN DIAGNOSTICS, INC. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeDHR  
CFR Regulation Number866.5775 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1984-02-24
Decision Date1984-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.